Psychosis in Parkinson's disease without dementia: Common and comorbid with other non-motor symptoms

Movement Disorders

Volumn 27, Issue 7, 2012, Pages 858-863

  Lee, Angela H ^a   Weintraub, Daniel ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognitively intact; Non demented; Parkinson's disease; Psychosis

Indexed keywords

AMANTADINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR;

ADULT; ARTICLE; AUDITORY HALLUCINATION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DELUSION; DELUSIONAL MISIDENTIFICATION; DEMENTIA; DEPRESSION; EYE MOVEMENT; FEMALE; HUMAN; ILLUSION; MAJOR CLINICAL STUDY; MALE; MOOD; MOTOR DYSFUNCTION; MULTICENTER STUDY; PARANOIA; PARASOMNIA; PARKINSON DISEASE; PERCEPTION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOSIS; RISK; SLEEP WAKING CYCLE; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION;

AGED; COGNITION DISORDERS; COMORBIDITY; DELUSIONS; DEMENTIA; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SLEEP DISORDERS;

EID: 84862685221     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25003     Document Type: Article

References (42)

1. Lauterbach EC. The neuropsychiatry of Parkinson's disease and related disorders. Psychiatr Clin North Am 2004; 27: 801-825.
2. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 492-496.
3. Schrag A. Psychiatric aspects of Parkinson's disease: an update. J Neurol 2004; 251: 795-804.
4. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-392.
5. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 2010; 67: 996-1001.
6. Fenelon G, Soulas T, Zenasni F, de Langavant LC. The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord 2010; 25: 763-766.
7. Friedman JH. Parkinson's disease psychosis 2010: a review article. Parkinsonism Relat Disord 2011; 16: 553-560.
8. Fénelon G, Goetz CG, Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology 2006; 66: 93-98.
9. Debs R, Cochen De Cock V, Negre-Pages L, Aristin M, Senard A, Rascol O. Thought disorders among non-demented outpatients with Parkinson's disease: prevalence and associated factors. J Neural Transm 2010; 117: 1183-1188.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
11. Svetel M, Smiljković T, Pekmezović T, Kostić V. Hallucinations in Parkinson's disease: cross-sectional study. Acta Neurol Belg 2012; 112: 33-37.
12. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
13. Factor SA, Feustel PJ, Freidman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003; 60: 1756-1761.
14. Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G. What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology 2010; 75: 1270-1276.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999; 56: 33-39.
16. Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010; 75: 1717-1725.
17. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2005; 287: 455-463.
18. Fahn S, Elton RL; the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, New Jersey, USA: Macmillan Health Care Information; 1987: 153-163.
19. Hoehn MH, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
20. Mavandadi S, Nazem S, Ten Have TR, et al. Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson's disease. Am J Geriatr Psychiatry 2009; 17: 986-995.
21. Friedberg G, Zoldan J, Weizman A, Melamed E. Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 1998; 21: 280-284.
22. Fernandez HH, Aarsland D, Fénelon G, et al. Scales to assess psychosis in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 484-500.
23. Rush AJ, Giles DE, Schlesser MA, Fulton SL, Weissenburger J, Burns C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1985; 18: 65-87.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
25. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26: 477-486.
26. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, California, USA: Consulting Psychologists Press; 1983.
27. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 629-635.
28. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
29. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4: 134-139.
30. PASW for Windows [computer program]. Version 20.0. Chicago, Illinois, USA: IBM; 2011.
31. Gallagher DA, Parkkinen L, O'sullivan SS, et al. Testing an aetiological model of visual hallucinations in Parkinson's disease. Brain 2011; 134: 3299-3309.
32. Fenelon G. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms. CNS Spectr 2008; 13(Suppl 4): 18-25.
33. Shine JM, Halliday GM, Naismith SL, Lewis SJG. Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks? Mov Disord 2011; 26: 2154-2159.
34. Morgante L, Colosimo C, Antonini A, et al. Psychosis associated to Parkinson's disease in early stages: relevance of cognitive decline and depression. J Neurol Neurosurg Psychiatry 2011; 83: 76-82.
35. Braak H, Rub U, Del Tredici K. Cognitive decline correlates with neuropathological stage in Parkinson's disease. J Neurol Sci 2006; 248: 255-258.
36. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in Parkinson's disease. Lancet Neurol 2010; 9: 1200-1213.
37. Politis M, Wu K, Loane C, et al. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010; 75: 1920-1927.
38. Hesse S, Meyer PM, Strecker K, et al. Monoamine transporter availability in Parkinson's disease patients with or without depression. Eur J Nucl Med Mol Imaging 2009; 36: 428-435.
39. Pacchetti C, Manni R, Zangaglia R, et al. Relationship between hallucinatons, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 2005; 20: 1439-1448.
40. Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegnerative disease. Brain 2007; 130: 2770-2788.
41. Arnulf I, Ferraye M, Fraix V, et al. Sleep induced by stimulationin in the human pedunculopontine nucleus area. Ann Neurol 2010; 67: 546-549.
42. Naismith SL, Lewis SJG. "DASH" symptoms in patients with Parkinson's disease: red flags for early cognitive decline. J Clin Neurosci 2011; 18: 352-355.